Sven M. Jacobson
Fondatore presso Critical Care Diagnostics, Inc.
Profilo
Sven M.
Jacobson is the founder of Critical Care Diagnostics, Inc. (founded in 2004) where he holds the title of Director.
He is also the founder of Remedy Pharmaceuticals, Inc. (founded in 2004) where he holds the title of Chief Executive Officer & Director.
Mr. Jacobson is also the founder of Martin Pharmaceuticals, Inc. Mr. Jacobson's current job(s) include being the Chief Executive Officer & Director at Woolsey Pharmaceuticals, Inc., a Director at ResoTher Pharma AS, and a Managing Partner at Embark Healthcare (since 2001).
Mr. Jacobson's former job(s) include being a Director at Access Scientific LLC.
Mr. Jacobson's education history includes undergraduate studies and an MBA from the University of the Witwatersrand.
Posizioni attive di Sven M. Jacobson
| Società | Posizione | Inizio |
|---|---|---|
Embark Healthcare
 Embark Healthcare Investment ManagersFinance Embark Healthcare (Embark Healthcare) is a ventures capital firm founded in 2001 by David M Geliebter. The firm is headquartered in New York. | Investitore di Private Equity | 01/01/2001 |
Critical Care Diagnostics, Inc.
 Critical Care Diagnostics, Inc. Medical SpecialtiesHealth Technology Critical Care Diagnostics, Inc. develops diagnostic tools. The firm offers Presage, a laboratory assay employing ST2 for the diagnosis and prognosis of cardiovascular disease. It also offers Aspect-PLUS ST2 test, a cardiac biomarker testing product that aids clinicians in assessing risk, making treatment decisions, evaluating therapy effectiveness, and monitoring patient care. The company was founded by Sven M. Jacobson and David M. Geliebter in 2004 and is headquartered in San Diego, CA. | Fondatore | 01/01/2004 |
Remedy Pharmaceuticals, Inc.
 Remedy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Remedy Pharmaceuticals, Inc. develops and commercializes pharmaceutical ingridients. It focuses on small molecule drugs for acute central nervous system disorders. The company was founded by David M. Geliebter and Sven M. Jacobson in 2004 and is headquartered in New York, NY. | Fondatore | 20/11/2009 |
Woolsey Pharmaceuticals, Inc.
 Woolsey Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Woolsey Pharmaceuticals, Inc. operates as a single-drug entity. It is focused on the treatment of rare, neurodegenerative diseases with its compound BRAVYL (Fasudil). The company was founded in 2019 and is headquartered in New York, NY. | Amministratore Delegato | - |
Martin Pharmaceuticals, Inc.
 Martin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Martin Pharmaceuticals, Inc. engages in manufacturing, fabricating and processing drugs. The company was founded by David M. Geliebter and Sven M. Jacobson and is headquartered in New York, NY. | Amministratore Delegato | - |
ResoTher Pharma AS
 ResoTher Pharma AS Pharmaceuticals: MajorHealth Technology ResoTher Pharma is a privately held clinical-stage biotech company based in Copenhagen, Denmark. ResoTher Pharma focuses on developing compounds that induce inflammatory resolution in cardiovascular diseases. The Danish company's lead compound, RTP-026, has shown to have a profound effect on reducing infarction size and restoring cardiac function to a pre-infarction level. ResoTher Pharma's mission is to create novel medicines that benefit patients in need by addressing unmet needs in CVD inflammation through endogenous immune regulatory pathways. The company was founded in 2016 by Thomas Jonassen and is privately owned by a group of prominent Danish investors. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Sven M. Jacobson
| Società | Posizione | Fine |
|---|---|---|
Access Scientific LLC
 Access Scientific LLC Medical SpecialtiesHealth Technology Access Scientific LLC develops vascular access devices. It offers The PICC WAND a clinically proven technique for placement of PICC-introducer/peelable sheaths. The company was founded in 2004 and is headquartered in San Diego, CA. | Direttore/Membro del Consiglio | - |
Formazione di Sven M. Jacobson
| University of the Witwatersrand | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Embark Healthcare
Embark Healthcare Investment ManagersFinance Embark Healthcare (Embark Healthcare) is a ventures capital firm founded in 2001 by David M Geliebter. The firm is headquartered in New York. | Finance |
Access Scientific LLC
Access Scientific LLC Medical SpecialtiesHealth Technology Access Scientific LLC develops vascular access devices. It offers The PICC WAND a clinically proven technique for placement of PICC-introducer/peelable sheaths. The company was founded in 2004 and is headquartered in San Diego, CA. | Health Technology |
Critical Care Diagnostics, Inc.
Critical Care Diagnostics, Inc. Medical SpecialtiesHealth Technology Critical Care Diagnostics, Inc. develops diagnostic tools. The firm offers Presage, a laboratory assay employing ST2 for the diagnosis and prognosis of cardiovascular disease. It also offers Aspect-PLUS ST2 test, a cardiac biomarker testing product that aids clinicians in assessing risk, making treatment decisions, evaluating therapy effectiveness, and monitoring patient care. The company was founded by Sven M. Jacobson and David M. Geliebter in 2004 and is headquartered in San Diego, CA. | Health Technology |
Remedy Pharmaceuticals, Inc.
Remedy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Remedy Pharmaceuticals, Inc. develops and commercializes pharmaceutical ingridients. It focuses on small molecule drugs for acute central nervous system disorders. The company was founded by David M. Geliebter and Sven M. Jacobson in 2004 and is headquartered in New York, NY. | Health Technology |
ResoTher Pharma AS
ResoTher Pharma AS Pharmaceuticals: MajorHealth Technology ResoTher Pharma is a privately held clinical-stage biotech company based in Copenhagen, Denmark. ResoTher Pharma focuses on developing compounds that induce inflammatory resolution in cardiovascular diseases. The Danish company's lead compound, RTP-026, has shown to have a profound effect on reducing infarction size and restoring cardiac function to a pre-infarction level. ResoTher Pharma's mission is to create novel medicines that benefit patients in need by addressing unmet needs in CVD inflammation through endogenous immune regulatory pathways. The company was founded in 2016 by Thomas Jonassen and is privately owned by a group of prominent Danish investors. | Health Technology |
Martin Pharmaceuticals, Inc.
Martin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Martin Pharmaceuticals, Inc. engages in manufacturing, fabricating and processing drugs. The company was founded by David M. Geliebter and Sven M. Jacobson and is headquartered in New York, NY. | Health Technology |
Woolsey Pharmaceuticals, Inc.
Woolsey Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Woolsey Pharmaceuticals, Inc. operates as a single-drug entity. It is focused on the treatment of rare, neurodegenerative diseases with its compound BRAVYL (Fasudil). The company was founded in 2019 and is headquartered in New York, NY. | Health Technology |
- Borsa valori
- Insiders
- Sven M. Jacobson
